{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:02:08Z","timestamp":1784736128681,"version":"3.55.0"},"reference-count":205,"publisher":"Elsevier","isbn-type":[{"value":"9780443470868","type":"print"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/bs.enz.2026.06.001","type":"book-chapter","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:34:20Z","timestamp":1782214460000},"page":"195-242","source":"Crossref","is-referenced-by-count":0,"title":["Carbonic anhydrase IX and XII"],"prefix":"10.1016","author":[{"given":"Katia","family":"D\u2019Ambrosio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Langella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona Maria","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Di Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.enz.2026.06.001_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189120","article-title":"Carbonic anhydrase IX: an atypical target for innovative therapies in cancer","volume":"1879","author":"Ronca","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/bs.enz.2026.06.001_bib0002","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.gene.2017.04.027","article-title":"Carbonic anhydrase XII functions in health and disease","volume":"623","author":"Waheed","year":"2017","journal-title":"Gene"},{"key":"10.1016\/bs.enz.2026.06.001_bib0003","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/ijc.2910540218","article-title":"Expression of MaTu-MN protein in human tumor cultures and in clinical specimens","volume":"54","author":"Z\u00e1vada","year":"1993","journal-title":"Int. J. Cancer"},{"key":"10.1016\/bs.enz.2026.06.001_bib0004","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2174\/138161208783877893","article-title":"Cancer-associated carbonic anhydrases and their inhibition","volume":"14","author":"Pastorek","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/bs.enz.2026.06.001_bib0005","doi-asserted-by":"crossref","first-page":"6776","DOI":"10.18632\/oncotarget.2882","article-title":"Carbonic anhydrase XII is a new therapeutic target to overcome chemoresistance in cancer cells","volume":"6","author":"Kopecka","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/bs.enz.2026.06.001_bib0006","doi-asserted-by":"crossref","first-page":"6494","DOI":"10.1158\/0008-5472.CAN-13-1110","article-title":"Antitumor efficacy of a monoclonal antibody that inhibits the activity of cancer-associated carbonic anhydrase XII","volume":"73","author":"Gondi","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/bs.enz.2026.06.001_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/S0002-9440(10)64038-2","article-title":"Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer","volume":"158","author":"Ivanov","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0008","first-page":"7075","article-title":"Hypoxia-inducible expression of tumor-associated carbonic anhydrases","volume":"60","author":"Wykoff","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/bs.enz.2026.06.001_bib0009","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1111\/j.1365-2559.2006.02523.x","article-title":"Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours","volume":"49","author":"Hynninen","year":"2006","journal-title":"Histopathology"},{"key":"10.1016\/bs.enz.2026.06.001_bib0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s00432-005-0068-2","article-title":"Tumor-associated carbonic anhydrases are linked to metastases in primary cervical cancer","volume":"132","author":"Kim","year":"2006","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0011","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1517\/13543776.2013.798648","article-title":"Anticancer carbonic anhydrase inhibitors: a patent review (2008-2013)","volume":"23","author":"Monti","year":"2013","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/bs.enz.2026.06.001_bib0012","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/0042-6822(92)90464-Z","article-title":"A novel quasi-viral agent, MaTu, is a two-component system","volume":"187","author":"Pastorekov\u00e1","year":"1992","journal-title":"Virology"},{"key":"10.1016\/bs.enz.2026.06.001_bib0013","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/BF01314029","article-title":"An unusual transmissible agent\u2013MaTu","volume":"118","author":"Z\u00e1vada","year":"1991","journal-title":"Arch. Virol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0014","first-page":"2877","article-title":"Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment","volume":"9","author":"Pastorek","year":"1994","journal-title":"Oncogene"},{"key":"10.1016\/bs.enz.2026.06.001_bib0015","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1006\/geno.1996.0223","article-title":"Human MN\/CA9 gene, a novel member of the carbonic anhydrase family: structure and exon to protein domain relationships","volume":"33","author":"Opavsk\u00fd","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/bs.enz.2026.06.001_bib0016","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/ijc.2910380406","article-title":"Monoclonal antibody G 250 recognizes a determinant present in renal-cell carcinoma and absent from normal kidney","volume":"38","author":"Oosterwdk","year":"1986","journal-title":"Int. J. Cancer"},{"key":"10.1016\/bs.enz.2026.06.001_bib0017","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/(SICI)1097-0215(20000315)85:6<865::AID-IJC21>3.0.CO;2-Q","article-title":"Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250","volume":"85","author":"Grabmaier","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/bs.enz.2026.06.001_bib0018","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1006\/geno.1998.5483","article-title":"Radiation hybrid mapping of the human MN\/CA9 locus to chromosome band 9p12-p13","volume":"53","author":"Nakagawa","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/bs.enz.2026.06.001_bib0019","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1053\/gast.1997.v112.pm9024293","article-title":"Carbonic anhydrase IX, MN\/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts","volume":"112","author":"Pastorekova","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/bs.enz.2026.06.001_bib0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/sj.bjc.6604111","article-title":"Alternative splicing variant of the hypoxia marker carbonic anhydrase IX expressed independently of hypoxia and tumour phenotype","volume":"98","author":"Barathova","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/bs.enz.2026.06.001_bib0021","doi-asserted-by":"crossref","first-page":"12596","DOI":"10.1073\/pnas.95.21.12596","article-title":"Down-regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild-type von Hippel-Lindau transgenes","volume":"95","author":"Ivanov","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.enz.2026.06.001_bib0022","doi-asserted-by":"crossref","first-page":"7608","DOI":"10.1073\/pnas.95.13.7608","article-title":"Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers","volume":"95","author":"T\u00fcreci","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.enz.2026.06.001_bib0023","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1177\/002215549804600409","article-title":"Immunohistochemistry of carbonic anhydrase isozyme IX (MN\/CA IX) in human gut reveals polarized expression in the epithelial cells with the highest proliferative capacity","volume":"46","author":"Saarnio","year":"1998","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0024","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/med.21497","article-title":"Inhibition of carbonic anhydrase IX targets primary tumors, metastases, and cancer stem cells: three for the price of one","volume":"38","author":"Supuran","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/bs.enz.2026.06.001_bib0025","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1200\/JCO.2003.11.132","article-title":"Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer","volume":"21","author":"Swinson","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0026","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1158\/1078-0432.CCR-05-0848","article-title":"Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis","volume":"12","author":"Haapasalo","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/bs.enz.2026.06.001_bib0027","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/A:1025702330207","article-title":"The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosis","volume":"81","author":"Colpaert","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/bs.enz.2026.06.001_bib0028","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/B978-0-444-63258-6.00010-X","article-title":"Tumor-associated carbonic anhydrases IX and XII","author":"Ondriskova","year":"2015","journal-title":"Carbonic Anhydrases as Biocatalysts: From Theory to Medical and Industrial Applications"},{"key":"10.1016\/bs.enz.2026.06.001_bib0029","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1215\/15228517-2007-065","article-title":"Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas","volume":"10","author":"Haapasalo","year":"2008","journal-title":"Neuro. Oncol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0030","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1215\/S1152851705000025","article-title":"Expression of hypoxia-inducible carbonic anhydrases in brain tumors","volume":"7","author":"Proescholdt","year":"2005","journal-title":"Neuro. Oncol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2009.01.001","article-title":"Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: a one transcription factor (HIF-1) show?","volume":"1795","author":"Kaluz","year":"2009","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/bs.enz.2026.06.001_bib0032","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-08-2470","article-title":"Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH","volume":"69","author":"Chiche","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/bs.enz.2026.06.001_bib0033","doi-asserted-by":"crossref","DOI":"10.1007\/s11307-015-0885-x","article-title":"Evaluation of CAIX and CAXII expression in breast cancer at varied O2 levels: CAIX is the superior surrogate imaging biomarker of tumor hypoxia","volume":"18","author":"Tafreshi","year":"2016","journal-title":"Mol. Imaging Biol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0034","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22168808","article-title":"Betulin sulfonamides as carbonic anhydrase inhibitors and anticancer agents in breast cancer cells","volume":"22","author":"G\u00fcttler","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2026.06.001_bib0035","doi-asserted-by":"crossref","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-\u03b1 to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science (80-)"},{"issue":"5516","key":"10.1016\/bs.enz.2026.06.001_bib0036","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"10.1016\/bs.enz.2026.06.001_bib0037","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M002740200","article-title":"Hypoxia inducible factor-\u03b1 binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein","volume":"275","author":"Cockman","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0038","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.bbrc.2005.08.111","article-title":"Signalling hypoxia by HIF hydroxylases","volume":"338","author":"Schofield","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.enz.2026.06.001_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2008.04.009","article-title":"Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway","volume":"30","author":"Kaelin","year":"2008","journal-title":"Mol. Cell"},{"key":"10.1016\/bs.enz.2026.06.001_bib0040","doi-asserted-by":"crossref","DOI":"10.3390\/cells12050798","article-title":"Transcriptional response to hypoxia: the role of HIF-1-associated co-regulators","volume":"12","author":"Yfantis","year":"2023","journal-title":"Cells"},{"key":"10.1016\/bs.enz.2026.06.001_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2012.01.021","article-title":"Hypoxia-inducible factors in physiology and medicine","volume":"148","author":"Semenza","year":"2012","journal-title":"Cell"},{"issue":"5","key":"10.1016\/bs.enz.2026.06.001_bib0042","first-page":"917","article-title":"Expression of the hypoxia marker carbonic anhydrase IX is critically dependent on SP1 activity. Identification of a novel type of hypoxia-responsive enhancer","volume":"63","author":"Kaluz","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/bs.enz.2026.06.001_bib0043","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/excr.2000.5139","article-title":"The von Hippel-Lindau tumor suppressor gene","volume":"264","author":"Kondo","year":"2001","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/bs.enz.2026.06.001_bib0044","doi-asserted-by":"crossref","first-page":"77819","DOI":"10.18632\/oncotarget.20836","article-title":"Lactate stimulates CA IX expression in normoxic cancer cells","volume":"8","author":"Panisova","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/bs.enz.2026.06.001_bib0045","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2016.05.042","article-title":"Paracrine induction of HIF by glutamate in breast cancer: EglN1 senses cysteine","volume":"166","author":"Briggs","year":"2016","journal-title":"Cell"},{"key":"10.1016\/bs.enz.2026.06.001_bib0046","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0002-9440(10)64048-5","article-title":"Expression of the hypoxia-inducible and tumor-associated carbonic anhydrases in ductal carcinoma in situ of the breast","volume":"158","author":"Wykoff","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0047","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjc.6600796","article-title":"Carbonic anhydrase XII is a marker of good prognosis in invasive breast carcinoma","volume":"88","author":"Watson","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/bs.enz.2026.06.001_bib0048","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-07-6151","article-title":"Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer","volume":"68","author":"Barnett","year":"2008","journal-title":"Cancer Res."},{"key":"10.1016\/bs.enz.2026.06.001_bib0049","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/0092-8674(95)90199-X","article-title":"The nuclear receptor superfamily: the second decade","volume":"83","author":"Mangelsdorf","year":"1995","journal-title":"Cell"},{"key":"10.1016\/bs.enz.2026.06.001_bib0050","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1101\/gad.1424806","article-title":"Sensors and signals: a coactivator\/corepressor\/epigenetic code for integrating signal-dependent programs of transcriptional response","volume":"20","author":"Rosenfeld","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/bs.enz.2026.06.001_bib0051","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00000658-199307000-00004","article-title":"Immunohistochemical and biochemical measurement of estrogen and progesterone receptors in primary breast cancer. Correlation of histopathology and prognostic factors","volume":"218","author":"Stierer","year":"1993","journal-title":"Ann. Surg."},{"key":"10.1016\/bs.enz.2026.06.001_bib0052","doi-asserted-by":"crossref","DOI":"10.4149\/neo_2018_180819N624","article-title":"High expression of carbonic anhydrase 12 (CA12) is associated with good prognosis in breast cancer","volume":"66","author":"Li","year":"2019","journal-title":"Neoplasma"},{"key":"10.1016\/bs.enz.2026.06.001_bib0053","doi-asserted-by":"crossref","DOI":"10.1038\/s41388-019-1062-5","article-title":"TFAP2C regulates carbonic anhydrase XII in human breast cancer","volume":"39","author":"Franke","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/bs.enz.2026.06.001_bib0054","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14215453","article-title":"CAXII is a surrogate marker for luminal breast tumors regulated by ER and GATA3","volume":"14","author":"Porras","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/bs.enz.2026.06.001_bib0055","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/ijc.25491","article-title":"Overexpression of carbonic anhydrase XII in tissues from resectable non-small cell lung cancers is a biomarker of good prognosis","volume":"128","author":"Ilie","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/bs.enz.2026.06.001_bib0056","doi-asserted-by":"crossref","DOI":"10.3109\/19396368.2015.1112699","article-title":"Estrogen and progesterone differentially regulate carbonic anhydrase II, III, IX, XII, and XIII in ovariectomized rat uteri","volume":"62","author":"Karim","year":"2016","journal-title":"Syst. Biol. Reprod. Med."},{"key":"10.1016\/bs.enz.2026.06.001_bib0057","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1021\/acschembio.7b00055","article-title":"Disclosing the interaction of carbonic anhydrase IX with Cullin-associated NEDD8-dissociated protein 1 by molecular modeling and integrated binding measurements","volume":"12","author":"Buonanno","year":"2017","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0058","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/acs.chemrev.4c00278","article-title":"Multiple binding modes of inhibitors to human carbonic anhydrases: an update on the design of isoform-specific modulators of activity","volume":"125","author":"D\u2019Ambrosio","year":"2025","journal-title":"Chem. Rev."},{"key":"10.1016\/bs.enz.2026.06.001_bib0059","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23051045","article-title":"Cancer drug development of carbonic anhydrase inhibitors beyond the active site","volume":"23","author":"Singh","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/bs.enz.2026.06.001_bib0060","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.bbapap.2009.07.027","article-title":"Carbonic anhydrase IX: biochemical and crystallographic characterization of a novel antitumor target","volume":"1804","author":"De Simone","year":"2010","journal-title":"Biochim. Biophys. Acta Proteins Proteom."},{"key":"10.1016\/bs.enz.2026.06.001_bib0061","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1007\/s00018-020-03697-3","article-title":"Intrinsically disordered features of carbonic anhydrase IX proteoglycan-like domain","volume":"78","author":"Langella","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/bs.enz.2026.06.001_bib0062","doi-asserted-by":"crossref","first-page":"27799","DOI":"10.1074\/jbc.M800938200","article-title":"Biochemical characterization of CA IX, one of the most active carbonic anhydrase isozymes","volume":"283","author":"Hilvo","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0063","doi-asserted-by":"crossref","first-page":"16233","DOI":"10.1073\/pnas.0908301106","article-title":"Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX","volume":"106","author":"Alterio","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.enz.2026.06.001_bib0064","doi-asserted-by":"crossref","first-page":"14212","DOI":"10.1073\/pnas.97.26.14212","article-title":"Purification and kinetic analysis of recombinant CA XII, a membrane carbonic anhydrase overexpressed in certain cancers","volume":"97","author":"Ulmasov","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.enz.2026.06.001_bib0065","doi-asserted-by":"crossref","first-page":"9545","DOI":"10.1073\/pnas.161301298","article-title":"Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells","volume":"98","author":"Whittington","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/bs.enz.2026.06.001_bib0066","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1517\/17460441.2013.795145","article-title":"Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors","volume":"8","author":"De Simone","year":"2013","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/bs.enz.2026.06.001_bib0067","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.bbrc.2012.02.038","article-title":"Crystal structure of the secretory isozyme of mammalian carbonic anhydrases CA VI: implications for biological assembly and inhibitor development","volume":"419","author":"Pilka","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.enz.2026.06.001_bib0068","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1107\/S0907444913007208","article-title":"X-ray structure of the first \u2018extremo-\u03b1-carbonic anhydrase\u2019, a dimeric enzyme from the thermophilic bacterium Sulfurihydrogenibium yellowstonense YO3AOP1","volume":"69","author":"Di Fiore","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/bs.enz.2026.06.001_bib0069","doi-asserted-by":"crossref","first-page":"3283","DOI":"10.1007\/s00018-018-2798-8","article-title":"Biochemical, biophysical and molecular dynamics studies on the proteoglycan-like domain of carbonic anhydrase IX","volume":"75","author":"Langella","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/bs.enz.2026.06.001_bib0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/978-94-007-7359-2_12","article-title":"Carbonic anhydrase IX as an imaging and therapeutic target for tumors and metastases","volume":"75","author":"Tafreshi","year":"2014","journal-title":"Subcell. Biochem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0071","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.bmc.2012.09.062","article-title":"Carbonic anhydrase IX as a target for metastatic disease","volume":"21","author":"Gieling","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0072","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1158\/0008-5472.CAN-10-4261","article-title":"Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors","volume":"71","author":"Lou","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/bs.enz.2026.06.001_bib0073","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2014.08.002","article-title":"Hypoxia-induced carbonic anhydrase IX as a target for cancer therapy: from biology to clinical use","volume":"31","author":"Pastorek","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0074","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.febslet.2004.10.043","article-title":"Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH","volume":"577","author":"\u0160vastov\u00e1","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/bs.enz.2026.06.001_bib0075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s00726-021-03063-y","article-title":"Post-translational modifications in tumor-associated carbonic anhydrases","volume":"54","author":"Di Fiore","year":"2022","journal-title":"Amino Acids"},{"key":"10.1016\/bs.enz.2026.06.001_bib0076","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2013.00400","article-title":"Carbonic anhydrase IX, a hypoxia-induced catalytic component of the pH regulating machinery in tumors","volume":"4","author":"Sedlakova","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0077","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01462","article-title":"CA IX stabilizes intracellular pH to maintain metabolic reprogramming and proliferation in hypoxia","volume":"10","author":"Benej","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0078","doi-asserted-by":"crossref","first-page":"5825","DOI":"10.1016\/j.bmcl.2009.08.088","article-title":"The proteoglycan region of the tumor-associated carbonic anhydrase isoform IX acts as anintrinsic buffer optimizing CO2 hydration at acidic pH values characteristic of solid tumors","volume":"19","author":"Innocenti","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.06.001_bib0079","doi-asserted-by":"crossref","first-page":"7558","DOI":"10.1158\/0008-5472.CAN-11-2520","article-title":"Phosphorylation of carbonic anhydrase IX controls its ability to mediate extracellular acidification in hypoxic tumors","volume":"71","author":"Ditte","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/bs.enz.2026.06.001_bib0080","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1016\/j.febslet.2009.10.060","article-title":"Intact intracellular tail is critical for proper functioning of the tumor-associated, hypoxia-regulated carbonic anhydrase IX","volume":"583","author":"Hulikova","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/bs.enz.2026.06.001_bib0081","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/s41388-019-1098-6","article-title":"CAIX forms a transport metabolon with monocarboxylate transporters in human breast cancer cells","volume":"39","author":"Ames","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/bs.enz.2026.06.001_bib0082","doi-asserted-by":"crossref","DOI":"10.1038\/srep13605","article-title":"Hypoxia-induced carbonic anhydrase IX facilitates lactate flux in human breast cancer cells by non-catalytic function","volume":"5","author":"Jamali","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/bs.enz.2026.06.001_bib0083","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1074\/jbc.M111.286062","article-title":"Carbonic anhydrase IX interacts with bicarbonate transporters in lamellipodia and increases cell migration via its catalytic domain","volume":"287","author":"Svastova","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0084","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112745","article-title":"CAIX regulates invadopodia formation through both a pH-dependent mechanism and interplay with actin regulatory proteins","volume":"20","author":"Debreova","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2026.06.001_bib0085","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.1038\/onc.2017.219","article-title":"The interactome of metabolic enzyme carbonic anhydrase IX reveals novel roles in tumor cell migration and invadopodia\/MMP14-mediated invasion","volume":"36","author":"Swayampakula","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/bs.enz.2026.06.001_bib0086","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0014-4827(03)00351-3","article-title":"Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with \u03b2-catenin","volume":"290","author":"\u0160vastov\u00e1","year":"2003","journal-title":"Exp. Cell. Res."},{"key":"10.1016\/bs.enz.2026.06.001_bib0087","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1242\/jcs.072207","article-title":"Carbonic anhydrase IX (CA9) modulates tumor-associated cell migration and invasion","volume":"124","author":"Shin","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/bs.enz.2026.06.001_bib0088","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2013.00271","article-title":"The effect of carbonic anhydrase IX on focal contacts during cell spreading and migration","volume":"4","author":"Csaderova","year":"2013","journal-title":"Front. Physiol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0089","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1048955","article-title":"Carving out its niche: a role for carbonic anhydrase IX in pre-metastatic niche development","volume":"4","author":"Chafe","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.enz.2026.06.001_bib0090","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1158\/0008-5472.CAN-14-3000","article-title":"Carbonic anhydrase IX promotes myeloid-derived suppressor cell mobilization and establishment of a metastatic niche by stimulating G-CSF production","volume":"75","author":"Chafe","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/bs.enz.2026.06.001_bib0091","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.3390\/ijms21124299","article-title":"CAIX-mediated control of LIN28\/let-7 axis contributes to metabolic adaptation of breast cancer cells to hypoxia","volume":"21","author":"Gibadulinova","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2026.06.001_bib0092","doi-asserted-by":"crossref","first-page":"5210","DOI":"10.1038\/onc.2012.550","article-title":"Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche","volume":"32","author":"Lock","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/bs.enz.2026.06.001_bib0093","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1080\/14756366.2020.1764549","article-title":"The carbonic anhydrase IX inhibitor SLC-0111 as emerging agent against the mesenchymal stem cell-derived pro-survival effects on melanoma cells","volume":"35","author":"Peppicelli","year":"2020","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0094","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abj0364","article-title":"Genome-wide synthetic lethal screen unveils novel CAIX-NFS1\/xCT axis as a targetable vulnerability in hypoxic solid tumors","volume":"7","author":"Chafe","year":"2021","journal-title":"Sci. Adv."},{"key":"10.1016\/bs.enz.2026.06.001_bib0095","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1021\/pr300565w","article-title":"Characterization of carbonic anhydrase IX interactome reveals proteins assisting its nuclear localization in hypoxic cells","volume":"12","author":"Buanne","year":"2013","journal-title":"J. Proteome Res."},{"key":"10.1016\/bs.enz.2026.06.001_bib0096","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.ejcb.2010.03.004","article-title":"Carbonic anhydrase XII promotes invasion and migration ability of MDA-MB-231 breast cancer cells through the p38 MAPK signaling pathway","volume":"89","author":"Hsieh","year":"2010","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0097","doi-asserted-by":"crossref","first-page":"9799","DOI":"10.1002\/jcp.26947","article-title":"Inhibition of smoothened in breast cancer cells reduces CAXII expression and cell migration","volume":"233","author":"Guerrini","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0098","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbrc.2019.06.040","article-title":"Carbonic anhydrase XII expression is linked to suppression of Sonic hedgehog ligand expression in triple negative breast cancer cells","volume":"516","author":"Guerrini","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/bs.enz.2026.06.001_bib0099","first-page":"995","article-title":"Overexpression of Hedgehog signaling molecules and its involvement in triple-negative breast cancer","volume":"2","author":"Tao","year":"2011","journal-title":"Oncol. Lett."},{"key":"10.1016\/bs.enz.2026.06.001_bib0100","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1111\/cas.12697","article-title":"Cooperatively transcriptional and epigenetic regulation of sonic hedgehog overexpression drives malignant potential of breast cancer","volume":"106","author":"Duan","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/bs.enz.2026.06.001_bib0101","first-page":"275","article-title":"Fibroblast activation protein-\u03b1 promotes the growth and migration of lung cancer cells via the PI3K and sonic hedgehog pathways","volume":"41","author":"Jia","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/bs.enz.2026.06.001_bib0102","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/B978-0-12-394622-5.00003-1","article-title":"Noncanonical Hedgehog signaling","volume":"88","author":"Brennan","year":"2012","journal-title":"Vitam. Horm."},{"key":"10.1016\/bs.enz.2026.06.001_bib0103","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1111\/j.1582-4934.2008.00491.x","article-title":"Hypoxia induces a hedgehog response mediated by HIF-1alpha","volume":"13","author":"Bijlsma","year":"2009","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/bs.enz.2026.06.001_bib0104","article-title":"HIF-1\u03b1 contributes to proliferation and invasiveness of neuroblastoma cells via SHH signaling","volume":"10","author":"Chen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/bs.enz.2026.06.001_bib0105","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000358327","article-title":"Natural history and clinical manifestations of hyponatremia and hyperchlorhidrosis due to carbonic anhydrase XII deficiency","volume":"81","author":"Feinstein","year":"2014","journal-title":"Horm. Res. Paediatr."},{"key":"10.1016\/bs.enz.2026.06.001_bib0106","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajhg.2010.10.008","article-title":"Hyperchlorhidrosis caused by homozygous mutation in CA12, encoding carbonic anhydrase XII","volume":"87","author":"Feldshtein","year":"2010","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/bs.enz.2026.06.001_bib0107","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00439-010-0930-4","article-title":"Autosomal recessive hyponatremia due to isolated salt wasting in sweat associated with a mutation in the active site of carbonic anhydrase 12","volume":"129","author":"Muhammad","year":"2011","journal-title":"Hum. Genet."},{"key":"10.1016\/bs.enz.2026.06.001_bib0108","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1113\/JP271378","article-title":"Essential role of carbonic anhydrase XII in secretory gland fluid and HCO3 (-) secretion revealed by disease causing human mutation","volume":"593","author":"Hong","year":"2015","journal-title":"J. Physiol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0109","doi-asserted-by":"crossref","first-page":"3876","DOI":"10.1002\/art.30607","article-title":"Identification of cell surface-specific markers to target human nucleus pulposus cells: expression of carbonic anhydrase XII varies with age and degeneration","volume":"63","author":"Power","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/bs.enz.2026.06.001_bib0110","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1177\/002215540004801203","article-title":"Expression of the membrane-associated carbonic anhydrase isozyme XII in the human kidney and renal tumors","volume":"48","author":"Parkkila","year":"2000","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0111","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00370.2001","article-title":"Carbonic anhydrase XII mRNA encodes a hydratase that is differentially expressed along the rabbit nephron","volume":"284","author":"Schwartz","year":"2003","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0112","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/sj.ki.5002020","article-title":"The role of carbonic anhydrases in renal physiology","volume":"71","author":"Purkerson","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/bs.enz.2026.06.001_bib0113","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1177\/002215540305100912","article-title":"Localization of carbonic anhydrase XII to the basolateral membrane of H+-secreting cells of mouse and rat kidney","volume":"51","author":"Kyll\u00f6nen","year":"2003","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0114","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1136\/jmg.40.4.257","article-title":"Expression of cell surface transmembrane carbonic anhydrase genes CA9 and CA12 in the human eye: overexpression of CA12 (CAXII) in glaucoma","volume":"40","author":"Liao","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/bs.enz.2026.06.001_bib0115","doi-asserted-by":"crossref","first-page":"4421","DOI":"10.1021\/cr200176r","article-title":"Multiple binding modes of inhibitors to carbonic anhydrases: how to design specific drugs targeting 15 different isoforms?","volume":"112","author":"Alterio","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/bs.enz.2026.06.001_bib0116","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108408","article-title":"Antibody-drug conjugates and radioconjugates targeting carbonic anhydrase IX and XII in hypoxic tumors: bench to clinical applications","volume":"159","author":"Nerella","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0117","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2025.1511281","article-title":"Dual targeting carbonic anhydrase inhibitors as promising therapeutic approach: a structural overview","volume":"12","author":"D\u2019Ambrosio","year":"2025","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/bs.enz.2026.06.001_bib0118","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/978-3-032-23172-7_3","article-title":"Drug design of carbonic anhydrase inhibitors","volume":"123","author":"Raghav","year":"2026","journal-title":"Subcell. Biochem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0119","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1021\/jm050333c","article-title":"Carbonic anhydrase inhibitors: stacking with Phe131 determines active site binding region of inhibitors as exemplified by the X-ray crystal structure of a membrane-impermeant antitumor sulfonamide complexed with isozyme II","volume":"48","author":"Menchise","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0120","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/14756366.2017.1405263","article-title":"Crystal structure of the human carbonic anhydrase II adduct with 1-(4-sulfamoylphenyl-ethyl)-2,4,6-triphenylpyridinium perchlorate, a membrane-impermeant, isoform selective inhibitor","volume":"33","author":"Alterio","year":"2018","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0121","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1080\/14756360009040695","volume":"15","author":"Supuran","year":"2000","journal-title":"J. Enzyme Inhib."},{"key":"10.1016\/bs.enz.2026.06.001_bib0122","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.104204","article-title":"Pyridinium derivatives of 3-aminobenzenesulfonamide are nanomolar-potent inhibitors of tumor-expressed carbonic anhydrase isozymes CA IX and CA XII","volume":"103","author":"Akocak","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0123","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1021\/jm990479+","article-title":"Carbonic anhydrase inhibitors: synthesis of membrane-impermeant low molecular weight sulfonamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes","volume":"43","author":"Scozzafava","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0124","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bmcl.2003.12.029","article-title":"Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX","volume":"14","author":"Pastorekova","year":"2004","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.06.001_bib0125","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/COC.0000000000000691","article-title":"A Phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors","volume":"43","author":"McDonald","year":"2020","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0126","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1021\/jm101541x","article-title":"Ureido-substituted benzenesulfonamides potently inhibit carbonic anhydrase IX and show antimetastatic activity in a model of breast cancer metastasis","volume":"54","author":"Pacchiano","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0127","unstructured":"A Study of SLC-0111 and Gemcitabine for Metastatic Pancreatic Ductal Cancer in Subjects Positive for CAIX (SLC_0111\u221217\u221201) clinical trial NCT03450018), 2024."},{"key":"10.1016\/bs.enz.2026.06.001_bib0128","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/14756366.2018.1532419","article-title":"The carbonic anhydrase IX inhibitor SLC-0111 sensitises cancer cells to conventional chemotherapy","volume":"34","author":"Andreucci","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0129","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105920","article-title":"A decade of tail-approach based design of selective as well as potent tumor associated carbonic anhydrase inhibitors","volume":"126","author":"Kumar","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0130","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1021\/acs.jmedchem.8b00770","article-title":"Discovery of 4-hydroxy-3-(3-(phenylureido)benzenesulfonamides as SLC-0111 analogues for the treatment of hypoxic tumors overexpressing carbonic anhydrase IX","volume":"61","author":"Bozdag","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0131","doi-asserted-by":"crossref","DOI":"10.1186\/s40164-025-00690-z","article-title":"An ureido-substituted benzenesulfonamide carbonic anhydrase inhibitor exerts a potent antitumor effect in vitro and in vivo","volume":"14","author":"Gazzaroli","year":"2025","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0132","doi-asserted-by":"crossref","first-page":"20438","DOI":"10.1021\/acs.jmedchem.4c01894","article-title":"4-(Pyrazolyl)benzenesulfonamide ureas as carbonic anhydrases inhibitors and hypoxia-mediated chemo-sensitizing agents in colorectal cancer cells","volume":"67","author":"Eldehna","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0133","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26020863","article-title":"Design, synthesis, anticancer screening, and mechanistic study of spiro-N-(4-sulfamoyl-phenyl)-1,3,4-thiadiazole-2-carboxamide derivatives","volume":"26","author":"El-Saghier","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2026.06.001_bib0134","doi-asserted-by":"crossref","DOI":"10.3390\/ijms251810006","article-title":"Hydrogen sulfide-releasing carbonic anhydrase inhibitors effectively suppress cancer cell growth","volume":"25","author":"Bonardi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2026.06.001_bib0135","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.101401.3","article-title":"Targeted anticancer pre-vinylsulfone covalent inhibitors of carbonic anhydrase IX","volume":"13","author":"Va\u0161kevi\u010dius","year":"2024","journal-title":"eLife"},{"key":"10.1016\/bs.enz.2026.06.001_bib0136","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16030401","article-title":"Combination of betulinic acid fragments and carbonic anhydrase inhibitors: a new drug targeting approach","volume":"16","author":"Bache","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/bs.enz.2026.06.001_bib0137","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/fcp.13032","article-title":"Acetazolamide suppresses the progression of hepatocellular carcinoma induced by diethylnitrosamine in Wistar albino rats","volume":"38","author":"Tamim","year":"2024","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0138","doi-asserted-by":"crossref","first-page":"15892","DOI":"10.1021\/acs.jmedchem.4c01563","article-title":"Harnessing nitric oxide-donating benzofuroxans for targeted inhibition of carbonic anhydrase IX in cancer","volume":"67","author":"Bua","year":"2024","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0139","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ejmech.2018.09.055","article-title":"l,8-naphthalimide based DNA intercalators and anticancer agents. A systematic review from 2007 to 2017","volume":"159","author":"Tomczyk","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107596","article-title":"Discovery of novel 1,8-naphthalimide piperazinamide based benzenesulfonamides derivatives as potent carbonic anhydrase IX inhibitors and ferroptosis inducers for the treatment of triple-negative breast cancer","volume":"150","author":"Liang","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0141","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1021\/ja809683v","article-title":"Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new class of suicide inhibitors","volume":"131","author":"Maresca","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/bs.enz.2026.06.001_bib0142","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1021\/jm901287j","article-title":"Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins","volume":"53","author":"Maresca","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0143","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103739","article-title":"Design, synthesis and biological evaluation of coumarin linked 1,2,4-oxadiazoles as selective carbonic anhydrase IX and XII inhibitors","volume":"98","author":"Thacker","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0144","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17071150","article-title":"Non-classical inhibition of carbonic anhydrase","volume":"17","author":"Lomelino","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2026.06.001_bib0145","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1016\/j.bmcl.2010.06.040","article-title":"Coumarins incorporating hydroxy- and chloro-moieties selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II","volume":"20","author":"Maresca","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.06.001_bib0146","doi-asserted-by":"crossref","first-page":"7255","DOI":"10.1016\/j.bmcl.2010.10.094","article-title":"7,8-Disubstituted- but not 6,7-disubstituted coumarins selectively inhibit the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII over the cytosolic ones I and II in the low nanomolar\/subnanomolar range","volume":"20","author":"Maresca","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.06.001_bib0147","doi-asserted-by":"crossref","first-page":"8271","DOI":"10.1021\/jm200983e","article-title":"Glycosyl coumarin carbonic anhydrase IX and XII inhibitors strongly attenuate the growth of primary breast tumors","volume":"54","author":"Touisni","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0148","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107168","article-title":"Coumarins-lipophilic cations conjugates: efficient mitocans targeting carbonic anhydrases","volume":"145","author":"Fuentes-Aguilar","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0149","doi-asserted-by":"crossref","first-page":"85861","DOI":"10.18632\/oncotarget.13040","article-title":"P-glycoprotein-mediated chemoresistance is reversed by carbonic anhydrase XII inhibitors","volume":"7","author":"Kopecka","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/bs.enz.2026.06.001_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2013.04.035","article-title":"Sulfonamides containing coumarin moieties selectively and potently inhibit carbonic anhydrases II and IX: design, synthesis, inhibitory activity and 3D-QSAR analysis","volume":"66","author":"Wang","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0151","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111284","article-title":"Synthesis and investigation of selective human carbonic anhydrase IX, XII inhibitors using coumarins bearing a sulfonamide or biotin moiety","volume":"404","author":"Begines","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/bs.enz.2026.06.001_bib0152","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110947","article-title":"Design, synthesis and mechanism study of coumarin-sulfonamide derivatives as carbonic anhydrase IX inhibitors with anticancer activity","volume":"393","author":"Lv","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/bs.enz.2026.06.001_bib0153","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2024.107759","article-title":"Mitigating the resistance of MCF-7 cancer cells to Doxorubicin under hypoxic conditions with novel coumarin based carbonic anhydrase IX and XII inhibitors","volume":"152","author":"Abdelaal","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0154","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1021\/jm301625s","article-title":"Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases","volume":"56","author":"Tars","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0155","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1021\/acs.jmedchem.5b00523","article-title":"6-Substituted sulfocoumarins are selective carbonic anhdydrase IX and XII inhibitors with significant cytotoxicity against colorectal cancer cells","volume":"58","author":"Grandane","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0156","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.bmc.2015.02.023","article-title":"Synthesis of 6-aryl-substituted sulfocoumarins and investigation of their carbonic anhydrase inhibitory action","volume":"23","author":"Grandane","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0157","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.bmcl.2014.01.076","article-title":"6-Triazolyl-substituted sulfocoumarins are potent, selective inhibitors of the tumor-associated carbonic anhydrases IX and XII","volume":"24","author":"Grandane","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/bs.enz.2026.06.001_bib0158","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.bmc.2014.01.043","article-title":"Synthesis of 6-tetrazolyl-substituted sulfocoumarins acting as highly potent and selective inhibitors of the tumor-associated carbonic anhydrase isoforms IX and XII","volume":"22","author":"Grandane","year":"2014","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0159","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105012","article-title":"Sulfocoumarins, specific carbonic anhydrase IX and XII inhibitors, interact with cancer multidrug resistant phenotype through pH regulation and reverse P-glycoprotein mediated resistance","volume":"138","author":"Podolski-Reni\u0107","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/bs.enz.2026.06.001_bib0160","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1021\/acs.jmedchem.5b01720","article-title":"Thioxocoumarins show an alternative carbonic anhydrase inhibition mechanism compared to coumarins","volume":"59","author":"Ferraroni","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0161","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.3892\/ijo.2014.2658","article-title":"Monoclonal antibody G250 targeting CA \u2168: binding specificity, internalization and therapeutic effects in a non-renal cancer model","volume":"45","author":"Zatovicova","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0162","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1200\/JCO.1993.11.4.738","article-title":"Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250","volume":"11","author":"Oosterwijk","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0163","first-page":"2729","article-title":"Phase I\/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma","volume":"4","author":"Divgi","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/bs.enz.2026.06.001_bib0164","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1200\/JCO.2011.41.2445","article-title":"Positron emission tomography\/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial","volume":"31","author":"Divgi","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0165","unstructured":"WILEX. Ariser, adjuvant RENCAREX immunotherapy phase III trial to study efficacy in non metastatic RCC. NCT00087022, 2017."},{"key":"10.1016\/bs.enz.2026.06.001_bib0166","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/jamaoncol.2016.4419","article-title":"Adjuvant weekly girentuximab following nephrectomy for high-risk renal cell carcinoma: the ARISER randomized clinical trial","volume":"3","author":"Chamie","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0167","doi-asserted-by":"crossref","DOI":"10.1200\/jco.2013.31.15_suppl.4507","article-title":"ARISER: a randomized double blind phase III study to evaluate adjuvant cG250 treatment versus placebo in patients with high-risk ccRCC\u2014results and implications for adjuvant clinical trials","volume":"31","author":"Belldegrun","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0168","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1054\/bjoc.2000.1111","article-title":"Human tumour-associated cell adhesion protein MN\/CA IX: identification of M75 epitope and of the region mediating cell adhesion","volume":"82","author":"Z\u00e1vada","year":"2000","journal-title":"Br. J. Cancer"},{"key":"10.1016\/bs.enz.2026.06.001_bib0169","first-page":"13","article-title":"Immunotargeting of human cervical carcinoma xenograft expressing CA IX tumor-associated antigen by 125I-labeled M75 monoclonal antibody","volume":"50","author":"Chrastina","year":"2003","journal-title":"Neoplasma"},{"key":"10.1016\/bs.enz.2026.06.001_bib0170","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ijc.11142","article-title":"Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma","volume":"105","author":"Chrastina","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"Suppl 4","key":"10.1016\/bs.enz.2026.06.001_bib0171","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1464-410X.2008.07649.x","article-title":"Immunohistochemical expression of carbonic anhydrase IX assessed over time and during treatment in renal cell carcinoma","volume":"101","author":"Jensen","year":"2008","journal-title":"BJU Int."},{"key":"10.1016\/bs.enz.2026.06.001_bib0172","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1002\/cncr.24163","article-title":"Carbonic anhydrase IX in bladder cancer: a diagnostic, prognostic, and therapeutic molecular marker","volume":"115","author":"Klatte","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/bs.enz.2026.06.001_bib0173","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/prot.21821","article-title":"Stabilization of antibody structure upon association to a human carbonic anhydrase IX epitope studied by X-ray crystallography, microcalorimetry, and molecular dynamics simulations","volume":"71","author":"Kr\u00e1l","year":"2008","journal-title":"Proteins"},{"key":"10.1016\/bs.enz.2026.06.001_bib0174","doi-asserted-by":"crossref","first-page":"44497","DOI":"10.1021\/acsomega.3c01934","article-title":"Selective tumor hypoxia targeting using M75 antibody conjugated photothermally active MoOx nanoparticles","volume":"8","author":"Annu\u0161ov\u00e1","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/bs.enz.2026.06.001_bib0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2020.102280","article-title":"Molecular targeting of bioconjugated graphene oxide nanocarriers revealed at a cellular level using label-free Raman imaging","volume":"30","author":"Bug\u00e1rov\u00e1","year":"2020","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/bs.enz.2026.06.001_bib0176","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2021.1999194","article-title":"Isolation and characterization of monoclonal antibodies against human carbonic anhydrase-IX","volume":"13","author":"Lenferink","year":"2021","journal-title":"MAbs"},{"key":"10.1016\/bs.enz.2026.06.001_bib0177","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00262-011-0980-z","article-title":"Generation and characterization of the first inhibitory antibody targeting tumour-associated carbonic anhydrase XII","volume":"60","author":"Battke","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/bs.enz.2026.06.001_bib0178","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/ijc.31607","article-title":"An inhibitory antibody targeting carbonic anhydrase XII abrogates chemoresistance and significantly reduces lung metastases in an orthotopic breast cancer model in vivo","volume":"143","author":"von Neubeck","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/bs.enz.2026.06.001_bib0179","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21249411","article-title":"Inhibitory monoclonal antibodies and their recombinant derivatives targeting surface-exposed carbonic anhydrase XII on cancer cells","volume":"21","author":"Stravinskiene","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/bs.enz.2026.06.001_bib0180","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.21873\/anticanres.13570","article-title":"Humanized monoclonal antibody blocking carbonic anhydrase 12 enzymatic activity leads to reduced tumor growth in vitro","volume":"39","author":"Uda","year":"2019","journal-title":"Anticancer Res."},{"key":"10.1016\/bs.enz.2026.06.001_bib0181","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3109\/14756366.2013.856424","article-title":"Monoclonal antibodies raised against 167-180 aa sequence of human carbonic anhydrase XII inhibit its enzymatic activity","volume":"29","author":"Dekaminaviciute","year":"2014","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0182","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.1016\/j.jmb.2019.10.022","article-title":"Biochemical and structural insights into carbonic anhydrase XII\/Fab6A10 complex","volume":"431","author":"Alterio","year":"2019","journal-title":"J. Mol. Biol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0183","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drup.2014.11.001","article-title":"Antibody-targeted drugs and drug resistance\u2014challenges and solutions","volume":"18","author":"Shefet-Carasso","year":"2015","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/bs.enz.2026.06.001_bib0184","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12092158","article-title":"Revolutionizing cancer treatment: recent advances in immunotherapy","volume":"12","author":"Ghemrawi","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/bs.enz.2026.06.001_bib0185","first-page":"1","article-title":"Monoclonal antibodies in cancer therapy","volume":"9","author":"Zahavi","year":"2020","journal-title":"Antibodies (Basel, Switzerland)"},{"key":"10.1016\/bs.enz.2026.06.001_bib0186","article-title":"Antibody drug conjugate: the \u201cbiological missile\u201d for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/bs.enz.2026.06.001_bib0187","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25204764","article-title":"Antibody-drug conjugates for cancer therapy","volume":"25","author":"Hafeez","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/bs.enz.2026.06.001_bib0188","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1158\/1535-7163.MCT-11-0523","article-title":"Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9","volume":"11","author":"Petrul","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/bs.enz.2026.06.001_bib0189","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01228","article-title":"A novel fully-human potency-matched dual cytokine-antibody fusion protein targets carbonic anhydrase IX in renal cell carcinomas","volume":"9","author":"De Luca","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0190","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/14756366.2021.2004593","article-title":"First studies on tumor associated carbonic anhydrases IX and XII monoclonal antibodies conjugated to small molecule inhibitors","volume":"37","author":"Testa","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0191","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1080\/14756366.2022.2052868","article-title":"Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies","volume":"37","author":"Kciuk","year":"2022","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0192","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113046","article-title":"Radiotracers for positron emission tomography (PET) targeting tumour-associated carbonic anhydrase isoforms","volume":"213","author":"Burianova","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0193","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106399","article-title":"PET radiotracers and fluorescent probes for imaging human carbonic anhydrase IX and XII in hypoxic tumors","volume":"133","author":"Nerella","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/bs.enz.2026.06.001_bib0194","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S1470-2045(24)00402-9","article-title":"[89Zr]Zr-girentuximab for PET\u2013CT imaging of clear-cell renal cell carcinoma: a prospective, open-label, multicentre, phase 3 trial","volume":"25","author":"Shuch","year":"2024","journal-title":"Lancet Oncol."},{"key":"10.1016\/bs.enz.2026.06.001_bib0195","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-025-07619-y","article-title":"Prospective pilot study with [89Zr]Zr-girentuximab PET\/CT: CA-IX imaging in metastatic triple negative breast cancer (OPALESCENCE)","volume":"53","author":"Rousseau","year":"2026","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/bs.enz.2026.06.001_bib0196","doi-asserted-by":"crossref","first-page":"18230","DOI":"10.1021\/jacs.5c05198","article-title":"Small organic carbonic anhydrase IX Ligands from DNA-encoded chemical libraries for tumor-targeted delivery of radionuclides","volume":"147","author":"M\u00fcller","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/bs.enz.2026.06.001_bib0197","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2967\/jnumed.123.267175","article-title":"First-in-human safety, imaging, and dosimetry of a carbonic anhydrase IX-targeting peptide, [68Ga]Ga-DPI-4452, in patients with clear cell renal cell carcinoma","volume":"65","author":"Hofman","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/bs.enz.2026.06.001_bib0198","doi-asserted-by":"crossref","first-page":"761","DOI":"10.2967\/jnumed.123.266309","article-title":"Preclinical characterization of DPI-4452: a 68Ga\/177Lu theranostic ligand for carbonic anhydrase IX","volume":"65","author":"Massi\u00e9re","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/bs.enz.2026.06.001_bib0199","first-page":"1884","article-title":"Value of [68Ga]Ga-NYM046 PET\/CT, in comparison with 18F-FDG PET\/CT, for diagnosis of clear cell renal cell carcinoma","volume":"65","author":"Lou","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/bs.enz.2026.06.001_bib0200","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1007\/s00259-024-06801-y","article-title":"Diagnostic efficacy of [68Ga]Ga-NY104 PET\/CT to identify clear cell renal cell carcinoma","volume":"51","author":"Zhu","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/bs.enz.2026.06.001_bib0201","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1007\/s00259-023-06248-7","article-title":"Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma","volume":"50","author":"Zhu","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/bs.enz.2026.06.001_bib0202","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s00259-024-07007-y","article-title":"Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NYM005 and initial experience in clear cell renal cell carcinoma: an interim analysis of a prospective trial","volume":"52","author":"Yang","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/bs.enz.2026.06.001_bib0203","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2967\/jnumed.115.170514","article-title":"A 99mTc-labeled ligand of carbonic anhydrase IX selectively targets renal cell carcinoma in vivo","volume":"57","author":"Krall","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/bs.enz.2026.06.001_bib0204","article-title":"Discovery of high-affinity ligands for prostatic acid phosphatase via DNA-encoded library screening enables targeted cancer therapy","volume":"10","author":"Georgiev","year":"2026","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/bs.enz.2026.06.001_bib0205","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/acscombsci.5b00124","article-title":"Cell-based selection expands the utility of DNA-encoded small-molecule library technology to cell surface drug targets: identification of novel antagonists of the NK3 tachykinin receptor","volume":"17","author":"Wu","year":"2015","journal-title":"ACS Comb. Sci."}],"container-title":["The Enzymes","Vertebrate Carbonic Anhydrases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604726000144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1874604726000144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:15:20Z","timestamp":1784733320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1874604726000144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9780443470868"],"references-count":205,"URL":"https:\/\/doi.org\/10.1016\/bs.enz.2026.06.001","relation":{},"ISSN":["1874-6047"],"issn-type":[{"value":"1874-6047","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]}}}